| 臺大學術典藏 |
2021-03-09T06:46:16Z |
DNA content of nasopharyngeal carcinoma: An independent prognostic indicator
|
Hsu M.-M.;Chiou C.-R.;Ko J.-Y.;Sheen T.-S.;Ruey-Long Hong;Ting L.-L.; Hsu M.-M.; Chiou C.-R.; Ko J.-Y.; Sheen T.-S.; RUEY-LONG HONG; Ting L.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:16Z |
Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: Experience with 60 cases
|
Hsu M.-M.;Ruey-Long Hong;Ting L.-L.;Ko J.-Y.;Sheen T.-S.;Lou P.-J.; Hsu M.-M.; RUEY-LONG HONG; Ting L.-L.; Ko J.-Y.; Sheen T.-S.; Lou P.-J. |
| 臺大學術典藏 |
2021-03-09T06:46:16Z |
Anaphylaxis after propocol infusion for Port-A-Cath insertion in a 35-year old man
|
Tsai M.-H.;Kuo P.-H.;Ruey-Long Hong;Yang P.-C.; Tsai M.-H.; Kuo P.-H.; RUEY-LONG HONG; Yang P.-C. |
| 臺大學術典藏 |
2021-03-09T06:46:15Z |
Prognostic value of multidrug resistance 1, glutathione-S-transferase-�k and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy
|
Hsu C.-H.;Chen C.-L.;Ruey-Long Hong;Chen K.-L.;Lin J.-F.;Cheng A.-L.; Hsu C.-H.; Chen C.-L.; RUEY-LONG HONG; Chen K.-L.; Lin J.-F.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:15Z |
Construction of single-chain interleukin-12 DNA plasmid to treat airway hyperresponsiveness in an animal model of asthma
|
Lee Y.-L.;Ye Y.-L.;Yu C.-I.;Wu Y.-L.;Lai Y.-L.;Ku P.-H.;Ruey-Long Hong;Chiang B.-L.; Lee Y.-L.; Ye Y.-L.; Yu C.-I.; Wu Y.-L.; Lai Y.-L.; Ku P.-H.; RUEY-LONG HONG; Chiang B.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:15Z |
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
|
Ruey-Long Hong;Ting L.-L.;Ko J.-Y.;Hsu M.-M.;Sheen T.-S.;Lou P.-J.;Wang C.-C.;Chung N.-N.;Lui L.T.; RUEY-LONG HONG; Ting L.-L.; Ko J.-Y.; Hsu M.-M.; Sheen T.-S.; Lou P.-J.; Wang C.-C.; Chung N.-N.; Lui L.T. |
| 臺大學術典藏 |
2021-03-09T06:46:14Z |
Quality of life in patients of nasopharyngeal carcinoma: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35
|
Chie W.-C.;Ruey-Long Hong;Lai C.-C.;Ting L.-L.;Hsu M.-M.; Chie W.-C.; RUEY-LONG HONG; Lai C.-C.; Ting L.-L.; Hsu M.-M. |
| 臺大學術典藏 |
2021-03-09T06:46:14Z |
Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and Tat: A kinetic and efficacy study
|
Tseng Y.-L.;Liu J.-J.;Ruey-Long Hong; Tseng Y.-L.; Liu J.-J.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:14Z |
Simple and efficient liposomal encapsulation of topotecan by ammonium sulfate gradient: Stability, pharmacokinetic and therapeutic evaluation
|
Liu J.-J.;Ruey-Long Hong;Cheng W.-F.;Hong K.;Chang F.-H.;Tseng Y.-L.; Liu J.-J.; RUEY-LONG HONG; Cheng W.-F.; Hong K.; Chang F.-H.; Tseng Y.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:14Z |
Alterations of BAT-26 identify a subset of gastric cancer with distinct clinicopathologic features and better postoperative prognosis
|
Wu M.-S.;Lee C.-W.;Sheu J.-C.;Shun C.-T.;Wang H.-P.;Ruey-Long Hong;Lee W.-J.;Lin J.-T.; Wu M.-S.; Lee C.-W.; Sheu J.-C.; Shun C.-T.; Wang H.-P.; RUEY-LONG HONG; Lee W.-J.; Lin J.-T. |
| 臺大學術典藏 |
2021-03-09T06:46:13Z |
Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma
|
Huang S.-Y.;Tang J.-L.;Yao M.;Ko B.-S.;Ruey-Long Hong;Tsai W.;Wang C.-H.;Tien H.-F.;Shen M.-C.;Chen Y.-C.; Huang S.-Y.; Tang J.-L.; Yao M.; Ko B.-S.; RUEY-LONG HONG; Tsai W.; Wang C.-H.; Tien H.-F.; Shen M.-C.; Chen Y.-C. |
| 臺大學術典藏 |
2021-03-09T06:46:13Z |
A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma
|
Ruey-Long Hong;Tseng Y.-L.; RUEY-LONG HONG; Tseng Y.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:13Z |
Treatment Outcome and Pattern of Failure in 77 Patients with Sinonasal Natural Killer/T-Cell or T-Cell Lymphoma
|
Li C.-C.;Tien H.-F.;Tang J.-L.;Yao M.;Chen Y.-C.;Su I.-J.;Hsu S.-M.;Ruey-Long Hong; Li C.-C.; Tien H.-F.; Tang J.-L.; Yao M.; Chen Y.-C.; Su I.-J.; Hsu S.-M.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:12Z |
Comparison of Clinical and Molecular Surveillance in Patients with Advanced Nasopharyngeal Carcinoma after Primary Therapy: The Potential Role of Quantitative Analysis of Circulating Epstein-Barr Virus DNA
|
Ruey-Long Hong;Lin C.-Y.;Ting L.-L.;Ko J.-Y.;Hsu M.-M.; RUEY-LONG HONG; Lin C.-Y.; Ting L.-L.; Ko J.-Y.; Hsu M.-M. |
| 臺大學術典藏 |
2021-03-09T06:46:12Z |
Effect of 5-Aminolevulinic Acid-Mediated Photodynamic Therapy on MCF-7 and MCF-7/ADR Cells
|
Tsai T.;Ruey-Long Hong;Tsai J.-C.;Lou P.-J.;Ling I.-F.;Chen C.-T.; Tsai T.; RUEY-LONG HONG; Tsai J.-C.; Lou P.-J.; Ling I.-F.; Chen C.-T. |
| 臺大學術典藏 |
2021-03-09T06:46:12Z |
Recent advances in the treatment of nasopharyngeal carcinoma
|
Chang J.T.-C.;Ko J.-Y.;Ruey-Long Hong; Chang J.T.-C.; Ko J.-Y.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:11Z |
Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate
|
Lin C.-H.;Yen R.-F.;Jeng Y.-M.;Tzen C.-Y.;Hsu C.;Ruey-Long Hong; Lin C.-H.; Yen R.-F.; Jeng Y.-M.; Tzen C.-Y.; Hsu C.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:11Z |
Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma
|
Chan A.T.C.;Hsu M.-M.;Goh B.C.;Hui E.P.;Liu T.-W.;Millward M.J.;Ruey-Long Hong;Whang-Peng J.;Ma B.B.Y.;To K.F.;Mueser M.;Amellal N.;Lin X.;Chang A.Y.; Chan A.T.C.; Hsu M.-M.; Goh B.C.; Hui E.P.; Liu T.-W.; Millward M.J.; RUEY-LONG HONG; Whang-Peng J.; Ma B.B.Y.; To K.F.; Mueser M.; Amellal N.; Lin X.; Chang A.Y. |
| 臺大學術典藏 |
2021-03-09T06:46:11Z |
Early restaging whole-body 18F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma
|
Yen R.-F.;Chen T.H.-H.;Ting L.-L.;Tzen K.-Y.;Pan M.-H.;Ruey-Long Hong; Yen R.-F.; Chen T.H.-H.; Ting L.-L.; Tzen K.-Y.; Pan M.-H.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:10Z |
Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma
|
Wang C.-C.;Chang J.-Y.;Liu T.-W.;Lin C.-Y.;Yu Y.-C.;Ruey-Long Hong; Wang C.-C.; Chang J.-Y.; Liu T.-W.; Lin C.-Y.; Yu Y.-C.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:10Z |
Response of refractory osteosarcoma to thalidomide and celecoxib
|
Tsai Y.-C.;Wu C.-T.;Ruey-Long Hong; Tsai Y.-C.; Wu C.-T.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:10Z |
Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma
|
Yen R.-F.;Ruey-Long Hong;Tzen K.-Y.;Pan M.-H.;Chen T.H.-H.; Yen R.-F.; RUEY-LONG HONG; Tzen K.-Y.; Pan M.-H.; Chen T.H.-H. |
| 臺大學術典藏 |
2021-03-09T06:46:10Z |
Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: Implication from age-period-cohort analysis
|
Hsu C.;Shen Y.-C.;Cheng C.-C.;Ruey-Long Hong;Chang C.-J.;Cheng A.-L.; Hsu C.; Shen Y.-C.; Cheng C.-C.; RUEY-LONG HONG; Chang C.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:09Z |
The Cost-utility Analysis of 18-Fluoro-2-Deoxyglucose Positron Emission Tomography in the Diagnosis of Recurrent Nasopharyngeal Carcinoma
|
Yen R.-F.; Yen M.-F.; RUEY-LONG HONG; Tzen K.-Y.; Chien C.-R.; Chen T.H.-H. |
| 臺大學術典藏 |
2021-03-09T06:46:09Z |
A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline
|
Ruey-Long Hong;Lin C.-H.;Chao T.-Y.;Kao W.-Y.;Wang C.-H.;Hsieh R.K.;Hwang W.-S.; RUEY-LONG HONG; Lin C.-H.; Chao T.-Y.; Kao W.-Y.; Wang C.-H.; Hsieh R.K.; Hwang W.-S. |
| 臺大學術典藏 |
2021-03-09T06:46:09Z |
Fatal thrombocytopenia after oxaliplatin-based chemotherapy
|
Shao Y.-Y.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:08Z |
Pleural metastases as a unique entity with dismal outcome of head and neck squamous cell carcinoma
|
Shao Y.-Y.;Ruey-Long Hong; Shao Y.-Y.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:08Z |
The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients
|
Yen R.-F.;Chen C.-Y.;Cheng M.-F.;Wu Y.-W.;Shiau Y.-C.;Wu K.;Ruey-Long Hong;Yu C.-J.;Wang K.-L.;Yang R.-S.; Yen R.-F.; Chen C.-Y.; Cheng M.-F.; Wu Y.-W.; Shiau Y.-C.; Wu K.; RUEY-LONG HONG; Yu C.-J.; Wang K.-L.; Yang R.-S. |
| 臺大學術典藏 |
2021-03-09T06:46:08Z |
Usefulness of 201Tl spect/CT relative to 18F-FDG PET/CT in detecting recurrent skull base nasopharyngeal carcinoma
|
Yen R.-F.; Ting L.-L.; Cheng M.-F.; Wu Y.-W.; Tzen K.-Y.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:08Z |
Nasion swelling as the presenting symptom of lung adenocarcinoma
|
Huang C.-T.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:07Z |
Clinicopathological features of salivary and non-salivary adenoid cystic carcinomas
|
Lin Y.-C.; Chen K.-C.; Lin C.-H.; Kuo K.-T.; Ko J.-Y.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:07Z |
Postoperative intensity-modulated radiotherapy for squamous cell carcinoma of the external auditory canal and middle ear: Treatment outcomes, marginal misses, and perspective on target delineation
|
Chen W.-Y.; Kuo S.-H.; Chen Y.-H.; Lu S.-H.; Tsai C.-L.; Chia-Hsien Cheng J.; RUEY-LONG HONG; Chen Y.-F.; Hsu C.-J.; Lin K.-N.; Ko J.-Y.; Lou P.-J.; Wang C.-P.; Chong F.-C.; Wang C.-W. |
| 臺大學術典藏 |
2021-03-09T06:46:07Z |
A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor
|
Yang S.-H.; Lin C.-C.; Lin Z.-Z.; Tseng Y.-L.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:06Z |
Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer
|
Chua D.T.T.; Yiu H.H.-Y.; Seetalarom K.; Ng A.W.-Y.; Kurnianda J.; Shotelersuk K.; Krishnan G.; RUEY-LONG HONG; Yang M.-H.; Wang C.-H.; Sze W.-K.; Ng W.-T. |
| 臺大學術典藏 |
2021-03-09T06:46:06Z |
Osteoradionecrosis of the upper cervical spine after radiation therapy for head and neck cancer: Differentiation from recurrent or metastatic disease with MR imaging
|
Wu L.-A.;Liu H.-M.;Wang C.-W.;Chen Y.-F.;Ruey-Long Hong;Ko J.-Y.; Wu L.-A.; Liu H.-M.; Wang C.-W.; Chen Y.-F.; RUEY-LONG HONG; Ko J.-Y. |
| 臺大學術典藏 |
2021-03-09T06:46:06Z |
Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy
|
Lin Z.-Z.; Hsu C.; Hu F.-C.; Shao Y.-Y.; Chang D.-Y.; Yang C.-H.; RUEY-LONG HONG; Hsu C.-H.; Chengb A.-L. |
| 臺大學術典藏 |
2021-03-09T06:46:05Z |
An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma
|
Le Q.-T.; Zhang Q.; Cao H.; Cheng A.-J.; Pinsky B.A.; RUEY-LONG HONG; Chang J.T.; Wang C.-W.; Tsao K.-C.; Lo Y.M.D.; Lee N.; Ang K.K.; Chan A.T.C.; Chan K.C.A. |
| 臺大學術典藏 |
2021-03-09T06:46:05Z |
Intensity-modulated radiation therapy for T4 nasopharyngeal carcinoma: Treatment results and locoregional recurrence
|
Chen J.L.-Y.; Huang Y.-S.; Kuo S.-H.; Chen Y.-F.; RUEY-LONG HONG; Ko J.-Y.; Lou P.-J.; Tsai C.-L.; Chen W.-Y.; Wang C.-W. |
| 臺大學術典藏 |
2021-03-09T06:46:05Z |
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: Final results of a randomized, double-blind, placebo-controlled, phase 3 study
|
Urba S.; Van Herpen C.M.L.; Sahoo T.P.; Shin D.M.; Licitra L.; Mezei K.; Reuter C.; Hitt R.; Russo F.; Chang S.-C.; Hossain A.M.; Frimodt-Moller B.; Koustenis A.; RUEY-LONG HONG |
| 臺大學術典藏 |
2021-03-09T06:46:05Z |
Identification of novel mutations of TP53, ALK and RET gene in metastatic thymic squamous cell carcinoma and its therapeutic implication
|
Hu Z.; Wang J.; Yao T.; RUEY-LONG HONG; Zhang K.; Gao H.; Wu X.; Li J.; Bai C.; Yen Y. |
| 臺大學術典藏 |
2021-03-09T06:46:04Z |
�\-Enolase-binding peptide enhances drug delivery efficiency and therapeutic efficacy against colorectal cancer
|
Wu C.-H.;Kuo Y.-H.;Ruey-Long Hong;Wu H.-C.; Wu C.-H.; Kuo Y.-H.; RUEY-LONG HONG; Wu H.-C. |
| 臺大學術典藏 |
2021-03-09T06:46:04Z |
Dual-effect liposomes encapsulated with doxorubicin and chlorin e6 augment the therapeutic effect of tumor treatment
|
Peng P.-C.;Ruey-Long Hong;Tsai Y.-J.;Li P.-T.;Tsai T.;Chen C.-T.; Peng P.-C.; RUEY-LONG HONG; Tsai Y.-J.; Li P.-T.; Tsai T.; Chen C.-T. |
| 臺大學術典藏 |
2021-03-09T06:46:04Z |
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in East Asian patients with recurrent or metastatic head and neck cancer: Results of an exploratory subgroup analysis of a phase III trial
|
Urba S.; RUEY-LONG HONG; Hossain A.M.; Cheng R.; Orlando M. |
| 臺大學術典藏 |
2021-03-09T06:46:03Z |
Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma
|
Chen J.L.;Huang Y.-S.;Kuo S.-H.;Ruey-Long Hong;Ko J.-Y.;Lou P.-J.;Wang C.-W.; Chen J.L.; Huang Y.-S.; Kuo S.-H.; RUEY-LONG HONG; Ko J.-Y.; Lou P.-J.; Wang C.-W. |
| 臺大學術典藏 |
2021-03-09T06:46:03Z |
Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma
|
Yang C.W.-C.;Wang C.-W.;Ruey-Long Hong;Tsai C.-L.;Yao M.;Tang J.-L.;Lin C.-W.;Cheng A.-L.;Kuo S.-H.; Yang C.W.-C.; Wang C.-W.; RUEY-LONG HONG; Tsai C.-L.; Yao M.; Tang J.-L.; Lin C.-W.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2021-03-09T06:46:03Z |
Histone methyltransferase G9a drives chemotherapy resistance by regulating the glutamate�Vcysteine ligase catalytic subunit in head and neck squamous cell carcinoma
|
Liu C.-W.;Hua K.-T.;Li K.-C.;Kao H.-F.;Ruey-Long Hong;Ko J.-Y.;Hsiao M.;Kuo M.-L.;Tan C.-T.; Liu C.-W.; Hua K.-T.; Li K.-C.; Kao H.-F.; RUEY-LONG HONG; Ko J.-Y.; Hsiao M.; Kuo M.-L.; Tan C.-T. |
| 臺大學術典藏 |
2021-03-09T06:46:02Z |
A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141
|
Kiyota N.;Hasegawa Y.;Takahashi S.;Yokota T.;Yen C.-J.;Iwae S.;Shimizu Y.;Ruey-Long Hong;Goto M.;Kang J.-H.;Sum Kenneth Li W.;Ferris R.L.;Gillison M.;Namba Y.;Monga M.;Lynch M.;Tahara M.; Kiyota N.; Hasegawa Y.; Takahashi S.; Yokota T.; Yen C.-J.; Iwae S.; Shimizu Y.; RUEY-LONG HONG; Goto M.; Kang J.-H.; Sum Kenneth Li W.; Ferris R.L.; Gillison M.; Namba Y.; Monga M.; Lynch M.; Tahara M. |
| 臺大學術典藏 |
2021-03-09T06:46:02Z |
Pembrolizumab for the treatment of advanced salivary gland carcinoma
|
Cohen R.B.;Delord J.-P.;Doi T.;Piha-Paul S.A.;Liu S.V.;Gilbert J.;Algazi A.P.;Damian S.;Ruey-Long Hong;Le Tourneau C.;Day D.;Varga A.;Elez E.;Wallmark J.;Saraf S.;Thanigaimani P.;Cheng J.;Keam B.; Cohen R.B.; Delord J.-P.; Doi T.; Piha-Paul S.A.; Liu S.V.; Gilbert J.; Algazi A.P.; Damian S.; RUEY-LONG HONG; Le Tourneau C.; Day D.; Varga A.; Elez E.; Wallmark J.; Saraf S.; Thanigaimani P.; Cheng J.; Keam B. |
| 臺大學術典藏 |
2021-03-09T06:46:02Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Ruey-Long Hong;Hsiao C.F.;Ting L.L.;Ko J.Y.;Wang C.W.;Chang J.T.C.;Lou P.J.;Wang H.M.;Tsai M.H.;Lai S.C.;Liu T.W.; RUEY-LONG HONG; Hsiao C.F.; Ting L.L.; Ko J.Y.; Wang C.W.; Chang J.T.C.; Lou P.J.; Wang H.M.; Tsai M.H.; Lai S.C.; Liu T.W. |
| 臺大學術典藏 |
2021-03-09T06:46:02Z |
Terminally Ill Taiwanese Cancer Patients�� and Family Caregivers�� Agreement on Patterns of Life-Sustaining Treatment Preferences Is Poor to Fair and Declines Over a Decade: Results From Two Independent Cross-Sectional Studies
|
Liu T.-W.;Wen F.-H.;Wang C.-H.;Ruey-Long Hong;Chow J.-M.;Chen J.-S.;Chiu C.-F.;Tang S.T.; Liu T.-W.; Wen F.-H.; Wang C.-H.; RUEY-LONG HONG; Chow J.-M.; Chen J.-S.; Chiu C.-F.; Tang S.T. |
